Account Executive - MI Clarity - Central US
Caris Life Sciences
August 20, 2026
On-site
Tennessee, United States
Sales
Position Summary
- Account Executive – MI Clarity drives awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay assessing early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer.
Job Responsibilities
- Educate healthcare providers/care teams on MI Clarity’s clinical utility and evidence.
- Present clinical data and explain how AI-driven pathology analysis differs from traditional assays.
- Lead in-person/virtual educational programs and consultative discussions on risk stratification, treatment planning, extended endocrine therapy, and reducing overtreatment/undertreatment.
- Serve as a clinical decision-support resource (performance, patient selection, workflow integration, turnaround time, interpretation).
- Develop territory/account plans; build relationships with oncologists, surgeons, pathologists, nurse navigators, and health system stakeholders.
- Identify KOLs/champions; support testing workflow and operational integration.
- Analyze performance data to find growth opportunities; maintain CRM documentation and forecasting.
- Collaborate cross-functionally (Medical Affairs, Marketing, Operations, Customer Support) and ensure compliant clinical/promotional communications.
Required Qualifications
- Bachelor’s degree (life sciences/healthcare preferred).
- 3+ years sales experience in oncology/diagnostics/molecular testing/pathology/medical device/pharma.
- Strong breast cancer treatment pathway knowledge; consultative selling.
- Ability to interpret and communicate clinical data; travel within assigned territory.
Preferred Qualifications
- Oncology diagnostics/precision medicine sales; existing oncology/breast-center relationships.
- New product/assay launch experience; pathology workflows/digital pathology familiarity.
- Knowledge of prognostic/predictive breast assays; experience with provider engagement, workflow implementation, territory growth, and CRM accuracy.
- Account Executive – MI Clarity drives awareness, adoption, and utilization of MI Clarity, an AI-powered prognostic assay assessing early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer.
Job Responsibilities
- Educate healthcare providers/care teams on MI Clarity’s clinical utility and evidence.
- Present clinical data and explain how AI-driven pathology analysis differs from traditional assays.
- Lead in-person/virtual educational programs and consultative discussions on risk stratification, treatment planning, extended endocrine therapy, and reducing overtreatment/undertreatment.
- Serve as a clinical decision-support resource (performance, patient selection, workflow integration, turnaround time, interpretation).
- Develop territory/account plans; build relationships with oncologists, surgeons, pathologists, nurse navigators, and health system stakeholders.
- Identify KOLs/champions; support testing workflow and operational integration.
- Analyze performance data to find growth opportunities; maintain CRM documentation and forecasting.
- Collaborate cross-functionally (Medical Affairs, Marketing, Operations, Customer Support) and ensure compliant clinical/promotional communications.
Required Qualifications
- Bachelor’s degree (life sciences/healthcare preferred).
- 3+ years sales experience in oncology/diagnostics/molecular testing/pathology/medical device/pharma.
- Strong breast cancer treatment pathway knowledge; consultative selling.
- Ability to interpret and communicate clinical data; travel within assigned territory.
Preferred Qualifications
- Oncology diagnostics/precision medicine sales; existing oncology/breast-center relationships.
- New product/assay launch experience; pathology workflows/digital pathology familiarity.
- Knowledge of prognostic/predictive breast assays; experience with provider engagement, workflow implementation, territory growth, and CRM accuracy.